InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
64,342.47
(
2.31%
)
Post# of 251706
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119567
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jbog post# 211698

Monday, 06/05/2017 5:02:05 PM

Monday, June 05, 2017 5:02:05 PM

Post# of 251706
Re: RVNC additional CD data

The main distinction between today’s dataset and the dataset reported on 5/18/17 is that today’s dataset allocates patients into the low-dose (“A”) or high-dose (“B”) subgroup according to the graphic on slide #9 at http://investors.revance.com/common/download/download.cfm?companyid=AMDA-2GNRV0&fileid=943515&filekey=5F1AE320-5FE5-4FFC-9E62-85DF1EA5CBE9&filename=Phase_2_Cervical_Dystonia_W24_PR_Slides.FINAL-2.pdf .

In RVNC’s 5/18/17 presentation (#msg-131479120), patients were grouped according to the raw enrollment cohorts, which caused noisy data insofar as the ranges of doses within the three cohorts overlapped to some degree.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up